These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 67631)
21. Treatment of prolymphocytic leukemia. Hollister D; Coleman M Cancer; 1982 Nov; 50(9):1687-9. PubMed ID: 6956431 [TBL] [Abstract][Full Text] [Related]
22. Splenectomy for massive splenomegaly: long-term results and risks for mortality. Taner T; Nagorney DM; Tefferi A; Habermann TM; Harmsen WS; Slettedahl SW; Donohue JH Ann Surg; 2013 Dec; 258(6):1034-9. PubMed ID: 23222031 [TBL] [Abstract][Full Text] [Related]
23. A preliminary study of low-dose splenic irradiation for the treatment of chronic lymphocytic and prolymphocytic leukaemias. Singh AK; Bates T; Wetherley-Mein G Scand J Haematol; 1986 Jul; 37(1):50-8. PubMed ID: 3489979 [TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in chronic lymphocytic leukaemia and their implications for therapy. Phillips EA; Kempin S; Passe S; Miké V; Clarkson B Clin Haematol; 1977 Feb; 6(1):203-22. PubMed ID: 334410 [No Abstract] [Full Text] [Related]
25. Splenectomy for splenomegaly exceeding 1000 grams: analysis of 47 patients. Letoquart JP; La Gamma A; Kunin N; Grosbois B; Mambrini A; Leblay R Br J Surg; 1993 Mar; 80(3):334-5. PubMed ID: 8472144 [TBL] [Abstract][Full Text] [Related]
26. Clinical staging of chronic lymphocytic leukemia. Rai KR; Sawitsky A; Cronkite EP; Chanana AD; Levy RN; Pasternack BS Blood; 1975 Aug; 46(2):219-34. PubMed ID: 1139039 [TBL] [Abstract][Full Text] [Related]
27. Malignant lymphoma diagnosed at splenectomy and idiopathic splenomegaly. A clinicopathologic comparison. Long JC; Aisenberg AC Cancer; 1974 Apr; 33(4):1054-61. PubMed ID: 4819212 [No Abstract] [Full Text] [Related]
29. "GIANT FOLLICLE LYMPHOMA OF THE SPLEEN". A CONDITION CLOSELY RELATED TO LYMPHATIC LEUKAEMIA BUT APPARENTLY CURABLE BY SPLENECTOMY. HICKLING RA Br Med J; 1964 Sep; 2(5412):787-90. PubMed ID: 14173848 [No Abstract] [Full Text] [Related]
36. Splenic enlargement and hyperfunction as indications for splenectomy in chronic leukemia. Mentzer SJ; Osteen RT; Starnes HF; Moloney WC; Rosenthal D; Canellos G; Wilson RE Ann Surg; 1987 Jan; 205(1):13-7. PubMed ID: 2432841 [TBL] [Abstract][Full Text] [Related]
37. Myelofibrosis and rapid thrombocytolysis. A case report. Kutti J; Bergström AL; Ridell B Acta Med Scand; 1977; 201(3):249-55. PubMed ID: 848365 [TBL] [Abstract][Full Text] [Related]
38. Risks and benefits of splenectomy in myelofibrosis: an analysis of 39 cases. Lafaye F; Rain JD; Clot P; Najean Y Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):359-62. PubMed ID: 7892130 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic leukapheresis in a patient with prolymphocytic transformation of B-cell chronic lymphocytic leukemia. Steenssens L; Van Camp B Int J Artif Organs; 1984 May; 7(3):139-42. PubMed ID: 6610651 [TBL] [Abstract][Full Text] [Related]